Introduction: Sulfonylureas have been associated with a high incidence of cardiovascular death in diabetic patients treated with these drugs. Although the evidence on the cardiovascular effects of sulfonylureas is contradictory and scarce, many experiments have shown that the second-generation compound glibenclamide has a protective effect on mechanical function and against generation of malignant arrhythmias. Objective: The purpose of this study was to assess whether glibenclamide elicits protection on postischemic myocardial functional recovery (stunning) and against reperfusion-induced arrhythmias in a conscious sheep model. Methods: Sheep were divided into three groups: control, glibenclamide (0.4 mg / kg) and vehicle. After a 12-min ischemic period, the heart was reperfused and recordings for index calculation were acquired during 2 h of reperfusion. Percent systolic wall thickening fraction (%WTH), radial diastolic compliance (CR), arrhythmia incidence and Bernauer's arrhythmia severity index (ASI) were calculated for each group. Results: Glibenclamide infusion had a high proarrhythmic action (ASI: glibenclamide 143, control 54 and vehicle 23; ANOVA P,0.001 drug vs. control and vehicle) and a detrimental effect on regional systolic (%WTH: glibenclamide 26.966.7, control 65.763.5 and vehicle 68.665.6, ANOVA P,0.01 drug vs. control and vehicle) and diastolic function (CR: glibenclamide 76.267.8, control 104.764.2 and vehicle 10664.9, ANOVA P,0.05 drug vs. control and vehicle) during reperfusion. Conclusions: Glibenclamide infusion resulted in adverse cardiovascular effects. The combined deleterious effects on reperfusion-induced arrhythmias and on myocardial recovery from stunning could be the cause of the unexplained high mortality in diabetic patients treated with sulfonylurea derivatives. The mechanism involved seems to be the blockade of the cardiac ATP sensitive potassium (K-ATP) channel.
Introduction
channel blocking sulfonylurea derivatives (e.g. glibenclamide) have been administered for many years to patients Recently, modulators of ATP sensitive potassium (Ksuffering from type II diabetes mellitus [8] . ATP) channels have received increasing interest because Because sulfonylurea derivatives not only have specific of their potential protective effect on the myocardium actions on pancreatic K-ATP channels but also on cardiac against myocardial postischemic dysfunction (stunning), K-ATP channels, they could have an important effect on infarction and prevention of malignant arrhythmias during the cardiovascular system [9] which might be either ischemia and reperfusion [1] [2] [3] [4] [5] .
adverse [10] or beneficial [11, 12] . For example, since Two types of K-ATP channel modulators have been K-ATP channels play a role in preserving cardiac function used in patients. K-ATP channel openers (e.g. pinacidil during ischemia [4] and in protecting against stunning and nicorandil) have been proposed in the treatment of [13] , their blockade by sulfonylureas has been found to hypertension and angina pectoris [6, 7] , while K-ATP impair the contractile recovery of the heart after an ischemic episode [4, 14] . On the contrary, K-ATP channel blockade by sulfonylureas and the subsequent prevention of action potential shortening [15] , similar to a class III total dose. A sterile thoracotomy was performed at the fifth antiarrhythmic effect, have led to the hypothesis that intercostal space. After pericardiotomy, a solid-state presblockade of K-ATP channels by these drugs might be sure microtransducer (Konigsberg P7, Pasadena, CA, antiarrhythmic [11, 12] . However, controversial findings USA) was inserted in the left ventricular cavity through a regarding the role of sulfonylureas in the protection against stab wound at the apical dimple to obtain left ventricular malignant arrhythmias [14, [16] [17] [18] ] and on contractile repressure (P). Tygon fluid-filled catheters were inserted in covery after an ischemic episode (myocardial stunning) the internal mammary vein (for drug infusion) and in the [4, 11, 13, 19 ] have been found in a variety of experimental left ventricle (for later calibration of the pressure mimodels. Furthermore, these compounds have been shown crotransducer). The left anterior descending coronary arto block myocardial protection afforded by preconditioning tery (LAD) was dissected free from adjacent tissue just in humans [20] and have been associated with a high risk distal to the second or third diagonal branch, and a of malignant arrhythmias and death in cardiovascular pneumatic cuff occluder was positioned around it. To patients treated with sulfonylureas for their diabetic disease obtain left ventricular wall thickness, a pair of piezoelectric [10, 21] . The importance of sulfonylureas in the clinical crystals (5 mHz) was placed within the zone to be rendered setting and their potential deleterious cardiovascular effects ischemic. Finally, a pair of steel multifilament wires was would indicate that the widespread use of these drugs in sutured to the right ventricular surface for electrocarcardiovascular patients should be reconsidered [21] .
diographic recordings and all wires and catheters were Although the effects of glibenclamide on arrhythmias tunneled subcutaneously to emerge between the scapulae. and myocardial function have been assessed in a variety of Cephalomicin 1 g / day i.m. was administered immediately animal models, there is no experience in a big conscious and for 3 days after surgery. The venous and ventricular animal where the results are not masked or influenced by catheters were flushed daily with sodium heparin (5000 U) sedatives, anesthetics, changes in body temperature, etc, of diluted in saline solution. particular importance in ischemia-reperfusion experiments. Thus, the purpose of this work was to study 2.3. Drugs whether K-ATP channel blockade by the most representative sulfonylurea compound, glibenclamide, participates in Glibenclamide (Sigma, St. Louis, MO, USA) was ischemia and reperfusion-induced arrhythmias and in left dissolved in a vehicle containing 1 M NaOH (1 ml), ventricular recovery from stunning in a conscious sheep ethanol (1 ml) and propylenglycol (1 ml). Then the model. solution was diluted with sodium chloride (290 mOsm / l) to a total volume of 20 ml. The dose for each animal was prepared on the day of the experiment and slowly infused 2. Methods for 10 min through a venous catheter. To avoid animal death, lidocaine (2 mg / kg, as a bolus) was infused at the 2.1. Animal treatment start of reperfusion when malignant arrhythmias appeared.
Fifty-seven male castrated Hampshire Down sheep aged 2.4. Experimental protocol 7-9 months, weighing 27-34 kg were used. On arrival to the animal house, they were deparasited with ivermectine, Seven to ten days after surgery, the animals were studied and vaccinated against tetanus, anthrax, gas gangrene and in the conscious, unsedated state. The fluid-filled ventricuclostridial enterotoxemia. Adequate health condition was lar catheter was connected to an external pressure transassessed by professional veterinary staff through clinical ducer (DT-XX, Viggo-Spectramed, Oxnard, CA, USA) examination and laboratory tests. The animals were previously calibrated using a transducer calibration system familiarized with the animal house personnel and the (Xcaliber, Viggo-Spectramed). The zero pressure point was laboratory environment and treated according to the Guide set approximately at the level of the right atrium, and the for the Care and Use Laboratory Animals, published by signal generated by the Konigsberg transducer was adthe US National Institute of Health (NIH publication No.
justed to match that of the external transducer. The 85-23, revised 1996). ultrasonic pair of crystals was connected to a sonomicrometer (Triton, San Diego, CA, USA) and calibrated in 2.2. Surgical procedures mm using the internal calibration. The electrocardiogram was recorded with an ECG Gould transducer. At each As previously described [22] , after sedation with acepacquisition time all signals were digitized at a 4-ms romazine maleate (0.3 mg / kg), anesthesia was induced interval for 15 s (3750 samples) using a personal computer with thiopental sodium (20 mg / kg). Following intubation equipped with an A / D converter (National Instruments and connection to mechanical ventilation (Neumovent 910, Lab-PC, Austin, TX, USA) and software developed in ouŕ Cordoba, Argentina), anesthesia was maintained with 3% laboratory. enflurane carried in oxygen and fentanyl citrate, 0.1 mg
The animals were divided into three groups: control, glibenclamide and vehicle treatment. An additional group electrode was placed on the epicardium within the zone to of six animals underwent all three protocols to compare the be rendered ischemic. Control recordings were taken in drug and vehicle effects in the same animal. In the control five sheep during basal, preischemia, ischemia (at 11 min group, after 20 min of basal recordings, the sheep underocclusion), and at 1 min of reperfusion. The remaining five went 12 min of complete ischemia followed by a reperfusheep were treated with glibenclamide (0.4 mg / kg), 30 sion period of 120 min. In the glibenclamide group, min before ischemia, and experimental recordings were glibenclamide at a dose of 0.4 mg / kg (maximum dose, 12 acquired as in control. Monophasic action potential duramg) was infused for 10 and 30 min before the 12-min tion (APD) was determined at a repolarization of 50% ischemic period. In the vehicle group, drug vehicle [1 M (APD ) and 90% (APD ) of maximal plateau amplitude.
90
NaOH (1 ml), ethanol (1 ml) and propyleneglycol (1 ml) diluted in sodium chloride solution (290 mOsm / l) to a 2.6. Data analysis total volume of 20 ml] was infused at the same time before ischemia as glibenclamide. When the different experimenEnd diastole was defined to occur at the onset of the tal conditions were imposed on the same sheep, each rapid upstroke of the digitally obtained time derivative of protocol was separated by 6-7 days to ensure complete left ventricular pressure (dP/dt). End systole was defined recovery of myocardial contractility (see Results) and as the time point where dP/dt reached 10% of its minimal performed at random to avoid any preconditioning-like value. This point was similar to that obtained in previous effect and / or the effects of potential coronary collateral experiments where the end-systolic point was defined as development.
the maximal value of the pressure / diameter ratio. End Experiments with glibenclamide vehicle were made to ejection was established to occur at peak negative dP/dt. rule out a hydroalcoholic solution effect on the hemoPercent wall thickening fraction (%WTH) was calcudynamic parameters which might indirectly promote arlated as rhythmia or a vehicle action on myocardial tissue which %WTH 5 100 (WTH -WTH ) / WTH could directly trigger malignant arrhythmias. End-diastolic radial compliance (CR) was defined as were acquired immediately before ischemia (preischemic [26] values), at 11 min of the ischemic period (ischemic values), and during reperfusion, every 5 min during the CR 5 de /ds 5 2 dP/ d (ln WTH) first hour and every 10 min during the second hour.
To ensure fully reversible ischemia, a 12-min ischemic where e is radial strain and s is radial stress. CR was period was used, because this short-term regional ischemia calculated as the slope of the linear fit of the pressure vs. ln induced considerable deterioration of myocardial function WTH relationship using the last 15-30 samples of each but did not result in myocyte death (as shown by beat depending on heart rate (HR). anatomopathologic studies in preliminary experiments).
At each acquisition time, end-systolic pressure (P ), es Another reason for choosing this ischemic period was the end-diastolic pressure (P ), HR, %WTH and CR were d relationship between reperfusion-induced malignant arcalculated from each recorded beat and the average of rhythmias and the duration of the preceding ischemic time processed beats was the value of the corresponding acqui-[23]. Even though 6 min was sufficient to trigger maligsition time. The value assigned to reperfusion for these nant arrhythmias in an anesthetized rat model [24] , this variables was the mean of the total reperfusion period, an period in sheep was insufficient either to trigger arrhythanalysis previously employed to study the behavior of mias or to elicit mechanical deterioration. Thus, we functional recovery [27] . This temporal mean was calcudecided to use 12 min of ischemia to study ventricular lated as the time integral (trapezoidal rule) of the variable tachycardia (VT) and ventricular fibrillation (VF) since it divided by total reperfusion duration. was a period close to that previously shown to induce high
To study the evolution of left ventricular regional incidence of VF [25], and not much longer than the function throughout the experiment and its recovery during ischemic time used in conscious sheep to study functional reperfusion, %WTH and CR were referred to their basal recovery after fully reversible regional ischemia [22] .
values considered as 100%. Arrhythmias were detected from the electrocardiogram 2.5. Epicardial monophasic action potential and the left ventricular pressure signal during ischemia and reperfusion, and diagnosed in accordance to the Lambeth To evaluate glibenclamide action on K-ATP channels, convention as VT, VF or other type of abnormal rhythm as the monophasic action potential was measured in a group single extrasystoles, salvos, etc. [28] . The severity of of ten open chest sheep. A Ag-AgCl suction bipolar arrhythmias was evaluated by Bernauer's arrhythmia se-verity index (ASI) [16] , an index which allows the 3. Results statistical comparison and calculation of significance in experiments with tachyarrhythmias.
Of fifty-seven operated sheep, five were discarded due to loss of signals or malfunctioning occluder. Of the remaining fifty-two animals (control, n516; glibenclamide, n5 2.7. Exclusion criteria 20 and vehicle, n510; additional group56) fifteen died during the reperfusion period. The results of thirty-seven The animals were excluded if they had poor-quality animals (control, n512; glibenclamide, n510; vehicle, electrocardiographic, wall thickening or pressure signals.
n59; additional group56) are thus reported for hemoSheep with VT at the onset of reperfusion received an dynamic and mechanical studies. intravenous bolus of lidocaine (2 mg / kg) to revert the malignant arrhythmia. When VT evolved to VF, cardiover-3.1. Hemodynamic data sion was done with one electric shock of 200 J (Rhomicron defibrillator, mod. 790, Argentina). If VT was reverted Hemodynamic data are summarized in Tables 1 and 2 . or defibrillation was successful, the animal continued the Although a significant rise in P was observed during d experiment and recordings were acquired over the reperfuischemia, it returned immediately to its preischemic values sion period for hemodynamic and mechanical measureduring reperfusion. HR and P remained unchanged es ments. The animal was not included for any study if more among treatments (control, glibenclamide and vehicle) and than one electric shock was needed or if it died. If after throughout the four experimental times (basal, preisthree consecutive electric shocks VF was not reverted, the chemia, ischemia and reperfusion). These results might be animal was sacrificed.
explained on the basis of the small ischemic area (less than 20% of the total left ventricular mass).
Statistical analysis 3.2. Arrhythmias
Multiple comparisons between groups for hemodynamic Table 3 shows that glibenclamide had a high proparameters, mechanical function, arrhythmia severity (Berarrhythmic effect when arrhythmia incidence and Bernauer's index) and APD were performed by the appropriate nauer's index were calculated. When the same group of ANOVA test (see tables and figures). When the F ratio was sheep was studied in the three experimental conditions, found to exceed the corresponding critical value for P, Bernauer's index was significantly higher in glibenclamidé 0.05, Scheffe's test was used to compare pairs of mean vs. control and vs. vehicle animals, but arrhythmia inci-2 values. To study arrhythmia incidence, a x test with dence did not show differences between experiments due Yate's correction for continuity was used. Values were to the small number of animals (Table 4) . Glibenclamide expressed as mean6S.E.M.
not only intensified the appearance of reperfusion-induced , P,0.01 (two-way ANOVA for repeated measures followed by Scheffe) when compared to basal and preischemic values. arrhythmias, but also had some pro-arrhythmic action control (25%) and vehicle (10%), it did not reach statisti-2 during ischemia (a few premature ectopic beats were seen cal significance (x test). in five animals). When tachyarrhythmias occurred, they appeared during the first 20 s of reperfusion and usually 3.3. Glibenclamide effects on action potential duration began with premature ectopic beats or salvos and sudden appearance of VT which turned into VF. In most cases, VT Fig. 1 and Table 5 show that in control, ischemia started without previous ectopic beats or salvos and turned shortened APD (percent change with respect to preissuddenly into VF. Although mortality due to VF in the chemia, APD 237.6563%; APD 230.0561.03%) 50 90 glibenclamide group (50%) was greater compared to and that this response was abolished by glibenclamide a VT, ventricular tachycardia; VF, ventricular fibrillation; Other, ventricular extrasystoles or salvos; n, animal number for each group; x /n, number of animals over the total number of animals. †, P,0.01 glibenclamide vs. control and ‡, P,0.001 glibenclamide vs. vehicle (one-way ANOVA for repeated measures followed by Scheffe). (percent change with respect to preischemia, APD 50 Table 6 0.6961%; APD 1.360.96%). Note that the recovery of (Fig. 2C and D) . ischemic period. Thus, since stunning must be studied only Although in our model, the combined VT and VF in conditions allowing full reversibility after an ischemic duration before successful cardioversion did not last more episode [29] , this result enabled use of the same animal for than 40 s, arrhythmia appearance could have had an effect the different experimental protocols.
on the subsequent myocardial functional recovery, per se Fig. 2 shows that glibenclamide strongly affected the or due to lidocaine infusion and / or lidocaine plus electric recovery of left ventricular regional systolic and diastolic cardioversion. Thus, to make sure that these possibilities mechanical function (measured as percent recovery of did not have any effect on measured functional recovery, %WTH and CR, respectively) after a fully reversible percent recovery of %WTH and CR were compared in ischemic episode. Although there was regional mechanical animals without arrhythmias against those with malignant deterioration during ischemia and reperfusion, global arrhythmias (VT) plus lidocaine (Fig. 3) and in animals systolic function remained unchanged (Tables 1 and 2) .
without arrhythmias at the start of reperfusion against Results in the three different groups of sheep showed a those with lidocaine plus electric cardioversion due to VT large decrease in the percentage recovery of %WTH (P, and VF (Fig. 4) recovery from stunning between animals, indicating that groups, ( Fig. 2A and B) . Similar results were found when neither lidocaine nor combined lidocaine plus cardioverthe same sheep were submitted to the three different sion had an additive deleterious effect on the depressant experimental protocols -glibenclamide strongly affecting action of glibenclamide on %WTH and CR. 
Discussion
of the drug on mechanical function is of major clinical interest. Although recovery from stunning has been studied The present study shows that the administration of in conscious animals [29] , there is no experience about glibenclamide results in a proarrhythmic effect at the start glibenclamide and postischemic functional improvement. of reperfusion in chronically instrumented conscious sheep Moreover, recovery from stunning has been studied in subjected to a sustained and reversible ischemic episode. most cases as recovery of systolic function (measured as Our results agree with those of Bernauer [16] in isolated ventricular developed pressure, %WTH or percent segment rat hearts and Cole et al. [4] and Shigematsu et al. [14] in shortening) and only a few studies have analyzed the guinea pig right ventricular walls. Conversely, many recovery of diastolic function [22, 31] . The present paper is authors have demonstrated that glibenclamide protects the first, to our knowledge, to report on the action of against malignant arrhythmias [3, 5, 30] or at least diglibenclamide on left ventricular regional function in a minishes the duration of arrhythmic episodes and increases conscious animal model. Glibenclamide deteriorated both the chance of spontaneous reversion of malignant arrhythsystolic and diastolic function, a result similar to that mias [19, 24, 25] . Another relevant finding is that the drug previously observed by Cole [4] and Shigematsu et al.
[14] impairs left ventricular mechanical recovery during rein guinea pig right ventricular wall and Mitani et al. [2] in perfusion. Since the persistence of myocardial contractile rat hearts. In contrast, Bril et al.
[19] found a protective dysfunction (stunning) after an ischemic episode strongly effect of this drug on ventricular function in rat hearts, affects morbidity and mortality [29] , the detrimental action albeit only during ischemia, and Auchampach et al.
[13] did not observe any glibenclamide action per se on during ischemia, and have shown a similar mechanism in postischemic systolic functional recovery in anesthetized afterdepolarization-induced cardiac arrhythmias [38] obdogs using a dose similar to that employed here. The served in other animal models. Thus, we think that within conflicting results are probably due to species differences, rationale limits, our conscious animal model is adequate to the experimental model (global versus regional ischemia, study ischemia and reperfusion-induced arrhythmias and anesthetized versus conscious animal) and the employed mechanical dysfunction. dose of glibenclamide.
Glibenclamide dosage 4.1. Animal model
Although there is no reported effect of glibenclamide in Sheep were chosen for several reasons: (a) they have sheep, the employed dose (0.4 mg / kg) resulted in a 2.5 been widely used to study the cardiovascular system in a mM plasma level, which was within the pharmacologic variety of experimental models; (b) experimental studies range [39] and effectively blocked the sarcolemmal [40] have shown a similar pattern in heart development and ( Fig. 1 and Table 5 ) and mitochondrial K-ATP channels coronary circulation of sheep and humans [32, 33] [24] (5 pooled data of preischemic values) was similar to that mg / kg) which are well beyond the range likely to be recorded for pigs [35] and dogs [36] , suggesting that the encountered in the clinical setting [39] . Regarding the sheep is an adequate species to study regional mechanics; hypoglycemic effect of the drug, it is noteworthy that (f) studies in sheep Purkinje fibers resemble the behavior although a significant decrease was mentioned in dogs [43] of action potential changes seen in cardiomyocytes [37] [probably due to the used dose (1 mg / kg) or a species- were preceded by prominent elevations in Ca levels. hearts without changes in the inotropic state or in oxygen 21 Conversely, the reduction in intracellular Ca resulted in consumption [46] . However, impaired postischemic rea significant decrease of VT and VF upon reperfusion [44] .
covery should not be attributed to this metabolic effect Afterdepolarization-induced triggered activity due to albecause an increase in ATP is more likely to improve, and 21 tered Ca inward current could be involved in sheep [38] . not to impair, cardiac function; (2) a decrease in coronary Afterdepolarization is a complex mechanism which implies blood flow [19, 30, 43] might be also considered as a cause two components [38] : (a) action potential lengthening (first of arrhythmogenesis and / or stunning. In rat hearts, a high or initiating phase) and (b) altered ionic inward current decrease in flow was described [16, 19] and correlated with (second or depolarization phase). It is noteworthy that the occurrence of VF. However, counteracting the glibenglibenclamide by K-ATP channel blockade leads to action clamide-induced vasoconstriction with sodium nitropruspotential lengthening (first phase) as observed in the side, a real antiarrrhythmic effect was not achieved [16] . 21 present study (Fig. 1 ) which might result in Ca overload Moreover, many authors have found a protective effect [4] (second phase). Thus, as demonstrated in sheep Puragainst arrhythmias even though there was a high decrease 21 kinje fibers [45] , Ca -induced triggered arrhythmias in coronary flow [3, 30, 43] . As for stunning and the during reperfusion appear to be the arrhythmogenic mechaprobable flow restriction by glibenclamide, we did not find 21 nism in our animal model. Regarding this Ca -related any differences in wall thickening and compliance meapathophysiology, it has been postulated that the K-ATP surements before and after drug infusion (see preischemic channel protective effect on myocardial contractile funcvalues compared to basal values in Figs. 2 and 4) . In our tion [1, 4, 13] might be due to action potential shortening as conscious model we cannot entirely rule out a vasocona consequence of K-ATP channel opening, leading to a strictive drug effect, but, if it existed, it was small enough 21 reduction in the time of Ca influx via voltage-gated not to produce any detrimental effect on myocardial channels and to an increase in the time during which the perfusion as corroborated by the maintenance of ventricu-
Na -Ca exchanger might operate to extrude Ca from lar dynamics (Tables 1 and 2 ). Work by Auchampach et al. 21 the cell. This would help to maintain intracellular Ca at using similar doses in anesthetized dogs seems to confirm physiological levels and might also indirectly reduce the our assumption [13] . Moreover, these authors showed a consumption of high energy phosphates stores which could detrimental action of the drug on myocardial recovery be lately used in contractile recovery [4] . Thus, glibenwhen a high dose (1 mg / kg) was used, although there clamide due to its K-ATP channel blocking effect leads to were no changes in myocardial perfusion. Conversely, in action potential lengthening (Fig. 1) which would finally the same animal and with the same glibenclamide dose, 21 result in Ca overload and a subsequent injury of the Billman et al. [43] reported a reduction of preischemic contractile apparatus. However, we cannot assure that flow and hyperemic response. However, these authors 21 Ca overload is the main and sole mechanism of glibenshowed that, although glibenclamide affects hyperemia, the 21 clamide-induced stunning, since Ca overload could coronary blood flow quickly returned to its preischemic secondarily lead to oxyradical genesis [29] which has also values, indicating that glibenclamide had no additional been mentioned as a cause of stunning and reperfusioneffects on vascular resistance during reperfusion. 21 induced arrhythmias. However, both Ca and / or oxyradiThus, these conflicting results about the effect of cal mechanisms are not mutually exclusive and may glibenclamide on myocardial blood flow suggest that this represent different features of the same pathophysiological is not the main mechanism involved in ischemia and sequence. Although the preceding explanation emphasizes reperfusion-induced arrhythmias and stunning. Finally, the Although it is probable that the reported undesired appears advisable to be cautious in sulfonylurea adminis- 
Conclusions

